Fig. 3From: Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic settingCost-effectiveness plane for targeted vaccination (depicted in red) and universal vaccination (depicted in green) using a societal perspective and a 3% discount rateBack to article page